Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02798224 · ClinicalTrials.gov registry record · NA
A Patient Portal Tool, E-assist, for Supporting CRC Screening
A NA study of Colorectal Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 1,826
- Enrollment target
- 1
- Study location
NCT02798224: Completed NA study of Colorectal Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT02798224 is a NA study of Colorectal Cancer that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 1,826 participants, above the 1,540-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02798224, a NA study of Colorectal Cancer, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,826 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare patient perceptions, intent to screen, and screening use among those using a patient portal with and without a colorectal cancer (CRC) screening decision support tool, e-assist. To evaluate whether the effectiveness of e-assist is moderated by multi-level factors, including patient health literacy, decision-making preference, and CRC screening decision stage. To assess program impact and create an implementation guide for e-assist by combining results from Aims 1 \& 2, a program implementation analysis/process evaluation and the perspectives of staff from future diverse implementation sites including small primary care practices, University-based primary practices and federally-qualified health centers.
Primary Outcome
For the evaluation, an intent-to-treat design with primary effectiveness measured by electronic health record (EHR)-documented CRC screening use. Effectiveness will be assessed among all trial enrollees and specific subgroups. Primary outcome is a binary variable reflecting CRC screening use at 12-months post-intervention as documented by the occurrence of any of the following: colonoscopy, flexible sigmoidoscopy, fecal occult blood testing, fecal immunochemical testing, or testing via Cologuard
Conditions Studied
Interventions
- BEHAVIORAL e-assist: Colon Health
- BEHAVIORAL Healthwise Educational Program
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,826 participants |
| Start Date | 2017-06-14 |
| Est. Completion | 2021-07-27 |
| Phase | NA |
What the finished NCT02798224 record still lists
NCT02798224 is an interventional study that assigns participants to a tested intervention. Its 1,826 participants enrollment target places it among the larger protocols in the corpus, above the 1,540-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (19% higher).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which e-assist: Colon Health is the first listed.
NCT02798224 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02798224 about?
NCT02798224 is a clinical study titled "A Patient Portal Tool, E-assist, for Supporting CRC Screening". To compare patient perceptions, intent to screen, and screening use among those using a patient portal with and without a colorectal cancer (CRC) screening decision support tool, e-assist. To evaluate whether the effectiveness of e-assist is moderated by multi-level factors, including patient healt...
What is the current status of trial NCT02798224?
This trial is currently completed. It is a NA study. The enrollment target is 1,826 participants. The study started on 2017-06-14. Estimated completion is 2021-07-27.
What conditions does trial NCT02798224 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT02798224?
The interventions under investigation include: e-assist: Colon Health (BEHAVIORAL), Healthwise Educational Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02798224?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02798224 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02798224's enrollment target sits among peer trials
1,826 34th of 381 higher than 348 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI